{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T14:11:16Z","timestamp":1779804676054,"version":"3.53.1"},"reference-count":23,"publisher":"American Society of Hematology","issue":"10","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,5,26]]},"abstract":"<jats:sec>\n                    <jats:title>Abstract<\/jats:title>\n                    <jats:p>Primary hemophagocytic lymphohistiocytosis (HLH) is mainly caused by biallelic variants in genes disrupting cytotoxic natural killer (NK) cell and T-cell function (PRF1, UNC13D, STX11, STXBP2, RAB27A, and LYST). A \u201cpathway defect accumulation\u201d model proposes that heterozygous variants in multiple familial hemophagocytic lymphohistiocytosis (FHL) genes (digenic or multigenic inheritance) may increase susceptibility, but its significance remains debated. We assessed the prevalence and clinical relevance of digenic\/multigenic FHL genotypes in a German FHL cohort (1987-2023) and the UK Biobank (UKB; 469\u2009589 participants). We analyzed (1) variants classified as disease mutations in the Human Gene Mutation database (HGMD); (2) common variants such as PRF1 p.Ala91Val and p.Asn252Ser; and (3) additional variants previously reported in digenic HLH and explored phenotypic associations using codes of the International Classification of Diseases, 10th Revision for possible HLH-related conditions. In the German cohort, among 635 individuals sequenced for &amp;gt;1 FHL gene, no symptomatic patient with abnormal NK\/cytotoxic T-lymphocyte degranulation carried digenic\/multigenic heterozygous variants. In UKB, 575 individuals carried digenic FHL genotypes (0.1% prevalence), without enrichment for HLH-associated phenotypes (odds ratio, 0.95; P = 1). Four individuals carried trigenic genotypes; none had HLH-related diagnoses. Several HGMD-labeled pathogenic variants were observed biallelically in asymptomatic adults, suggesting potential misclassification. Including PRF1 p.Ala91Val and p.Asn252Ser increased digenic variant carriers to 2590 but did not cause phenotype enrichment. Digenic heterozygous FHL variants are relatively common in the general population but do not confer increased FHL risk. Many reported pathogenic FHL variants may be benign. These findings argue against classifying multigenic heterozygous carriers as at risk and support integrating population data into variant interpretation.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1182\/bloodadvances.2025018781","type":"journal-article","created":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T20:30:27Z","timestamp":1774989027000},"page":"3606-3614","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":0,"title":["Digenic and multigenic heterozygous FHL genotypes are common but clinically silent in the general population"],"prefix":"10.1182","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8700-4335","authenticated-orcid":false,"given":"Oleg","family":"Borisov","sequence":"first","affiliation":[{"name":"1Institute of Genetic Epidemiology, Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8934-0639","authenticated-orcid":false,"given":"Jasmin","family":"Mann","sequence":"additional","affiliation":[{"name":"2Institute for Immunodeficiency, Center for Chronic Immunodeficiency, Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin Kim","family":"Walz","sequence":"additional","affiliation":[{"name":"1Institute of Genetic Epidemiology, Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florian","family":"Oyen","sequence":"additional","affiliation":[{"name":"3Division of Pediatric Stem Cell Transplantation and Immunology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7330-744X","authenticated-orcid":false,"given":"Helena Clara","family":"Lichtenfeld","sequence":"additional","affiliation":[{"name":"3Division of Pediatric Stem Cell Transplantation and Immunology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai","family":"Lehmberg","sequence":"additional","affiliation":[{"name":"3Division of Pediatric Stem Cell Transplantation and Immunology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4671-3714","authenticated-orcid":false,"given":"Anna","family":"K\u00f6ttgen","sequence":"additional","affiliation":[{"name":"1Institute of Genetic Epidemiology, Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9265-2721","authenticated-orcid":false,"given":"Stephan","family":"Ehl","sequence":"additional","affiliation":[{"name":"2Institute for Immunodeficiency, Center for Chronic Immunodeficiency, Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9391-0761","authenticated-orcid":false,"given":"Oliver","family":"Wegehaupt","sequence":"additional","affiliation":[{"name":"2Institute for Immunodeficiency, Center for Chronic Immunodeficiency, Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany"},{"name":"4Division of Pediatric Hematology and Oncology, Department of Pediatrics and Adolescent Medicine, Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","published-online":{"date-parts":[[2026,5,15]]},"reference":[{"issue":"5","key":"2026052609263497500_bib1","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1097\/GIM.0b013e318172dcdf","article-title":"Synergistic heterozygosity for TGFbeta1 SNPs and BMPR2 mutations modulates the age at diagnosis and penetrance of familial pulmonary arterial hypertension","volume":"10","author":"Phillips","year":"2008","journal-title":"Genet Med"},{"key":"2026052609263497500_bib2","first-page":"11","article-title":"The digenic causality in familial hypercholesterolemia: revising the genotype\u2013phenotype correlations of the disease","author":"Kamar","year":"2021","journal-title":"Front Genet"},{"issue":"6","key":"2026052609263497500_bib3","doi-asserted-by":"crossref","first-page":"584","DOI":"10.3390\/jpm14060584","article-title":"Digenic inheritance of mutations in homologous recombination genes in cancer patients","volume":"14","author":"Freire","year":"2024","journal-title":"J Pers Med"},{"issue":"2","key":"2026052609263497500_bib4","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.ajhg.2018.12.015","article-title":"Assessing the pathogenicity, penetrance, and expressivity of putative disease-causing variants in a population setting","volume":"104","author":"Wright","year":"2019","journal-title":"Am J Hum Genet"},{"key":"2026052609263497500_bib5","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.3389\/fimmu.2017.01965","article-title":"Clinical implications of digenic inheritance and epistasis in primary immunodeficiency disorders","volume":"8","author":"Ameratunga","year":"2017","journal-title":"Front Immunol"},{"key":"2026052609263497500_bib6","doi-asserted-by":"crossref","first-page":"777851","DOI":"10.3389\/fimmu.2021.777851","article-title":"Digenic inheritance: evidence and gaps in hemophagocytic lymphohistiocytosis","volume":"12","author":"Steen","year":"2021","journal-title":"Front Immunol"},{"issue":"8","key":"2026052609263497500_bib7","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1182\/blood-2014-05-573105","article-title":"Synergistic defects of different molecules in the cytotoxic pathway lead to clinical familial hemophagocytic lymphohistiocytosis","volume":"124","author":"Zhang","year":"2014","journal-title":"Blood"},{"issue":"8","key":"2026052609263497500_bib8","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1182\/blood.2019003487","article-title":"Prevalence and disease predisposition of p.A91V perforin in an aged population of European ancestry","volume":"135","author":"Voskoboinik","year":"2020","journal-title":"Blood"},{"issue":"25","key":"2026052609263497500_bib9","doi-asserted-by":"crossref","first-page":"2992","DOI":"10.1182\/blood.2024027954","article-title":"Beyond genotype: challenges in predicting disease risk for carriers of biallelic perforin variants","volume":"145","author":"Wegehaupt","year":"2025","journal-title":"Blood"},{"issue":"19","key":"2026052609263497500_bib10","first-page":"2330","article-title":"A cell-based functional assay that accurately links genotype to phenotype in familial HLH","volume":"141","author":"Noori","year":"2023","journal-title":"Blood"},{"issue":"1","key":"2026052609263497500_bib11","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.jaci.2023.07.023","article-title":"Severe adult hemophagocytic lymphohistiocytosis (HLHa) correlates with HLH-related gene variants","volume":"153","author":"Bloch","year":"2023","journal-title":"J Allergy Clin Immunol"},{"issue":"12","key":"2026052609263497500_bib12","doi-asserted-by":"crossref","first-page":"4700","DOI":"10.1182\/blood-2004-12-4935","article-title":"A functional analysis of the putative polymorphisms A91V and N252S and 22 missense perforin mutations associated with familial hemophagocytic lymphohistiocytosis","volume":"105","author":"Voskoboinik","year":"2005","journal-title":"Blood"},{"issue":"17","key":"2026052609263497500_bib13","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.1182\/blood-2015-12-688960","article-title":"Polygenic mutations in the cytotoxicity pathway increase susceptibility to develop HLH immunopathology in mice","volume":"127","author":"Sepulveda","year":"2016","journal-title":"Blood"},{"issue":"17","key":"2026052609263497500_bib14","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.1182\/blood-2016-03-700609","article-title":"HLH susceptibility: genetic lesions add up","volume":"127","author":"Meeths","year":"2016","journal-title":"Blood"},{"issue":"1","key":"2026052609263497500_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaci.2015.06.048","article-title":"Genetic predisposition to hemophagocytic lymphohistiocytosis: report on 500 patients from the Italian registry","volume":"137","author":"Cetica","year":"2016","journal-title":"J Allergy Clin Immunol"},{"issue":"12","key":"2026052609263497500_bib16","doi-asserted-by":"crossref","first-page":"2754","DOI":"10.1182\/blood-2011-08-374199","article-title":"A prospective evaluation of degranulation assays in the rapid diagnosis of familial hemophagocytic syndromes","volume":"119","author":"Bryceson","year":"2012","journal-title":"Blood"},{"issue":"8","key":"2026052609263497500_bib17","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1007\/s10875-017-0443-1","article-title":"Effective immunological guidance of genetic analyses including exome sequencing in patients evaluated for hemophagocytic lymphohistiocytosis","volume":"37","author":"Ammann","year":"2017","journal-title":"J Clin Immunol"},{"issue":"7886","key":"2026052609263497500_bib18","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1038\/s41586-021-04103-z","article-title":"Exome sequencing and analysis of 454,787 UK Biobank participants","volume":"599","author":"Backman","year":"2021","journal-title":"Nature"},{"issue":"6","key":"2026052609263497500_bib19","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1007\/s00439-017-1779-6","article-title":"The Human Gene Mutation Database: towards a comprehensive repository of inherited mutation data for medical research, genetic diagnosis and next-generation sequencing studies","volume":"136","author":"Stenson","year":"2017","journal-title":"Hum Genet"},{"key":"2026052609263497500_bib20","unstructured":"UK Biobank\n          . First Occurrence of Health Outcomes Defined by 3-Character ICD10 Code. Accessed 5 December 2025. https:\/\/www.ukbiobank.ac.uk."},{"key":"2026052609263497500_bib21","doi-asserted-by":"crossref","first-page":"448","DOI":"10.3389\/fimmu.2013.00448","article-title":"Graded defects in cytotoxicity determine severity of hemophagocytic lymphohistiocytosis in humans and mice","volume":"4","author":"Jessen","year":"2013","journal-title":"Front Immunol"},{"issue":"2","key":"2026052609263497500_bib22","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1111\/bjh.14147","article-title":"Advances in the pathogenesis of primary and secondary haemophagocytic lymphohistiocytosis: differences and similarities","volume":"174","author":"Brisse","year":"2016","journal-title":"Br J Haematol"},{"issue":"8048","key":"2026052609263497500_bib23","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1038\/s41586-024-08346-4","article-title":"Monoallelic expression can govern penetrance of inborn errors of immunity","volume":"637","author":"Stewart","year":"2025","journal-title":"Nature"}],"container-title":["Blood Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/10\/10\/3606\/2519786\/blooda_adv-2025-018781-main.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/10\/10\/3606\/2519786\/blooda_adv-2025-018781-main.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T13:26:44Z","timestamp":1779802004000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article\/10\/10\/3606\/567503\/Digenic-and-multigenic-heterozygous-FHL-genotypes"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,15]]},"references-count":23,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,5,26]]}},"URL":"https:\/\/doi.org\/10.1182\/bloodadvances.2025018781","relation":{},"ISSN":["2473-9529","2473-9537"],"issn-type":[{"value":"2473-9529","type":"print"},{"value":"2473-9537","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,5,26]]},"published":{"date-parts":[[2026,5,15]]}}}